Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Down 45.9% in June

Raia Drogasil S.A. (OTCMKTS:RADLY) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totaling 5,594 shares, a decrease of 45.9% from the May 31st total of 10,333 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 125,379 shares, the days-to-cover ratio is currently 0.0 days.

Raia Drogasil Price Performance

Shares of Raia Drogasil stock remained flat at $3.61 during midday trading on Thursday. The company had a trading volume of 7,119 shares, compared to its average volume of 58,201. The company’s 50 day moving average is $3.83 and its 200 day moving average is $4.37. Raia Drogasil has a one year low of $2.25 and a one year high of $5.34.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Raia Drogasil currently has a consensus rating of “Hold”.

Raia Drogasil Company Profile

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.